
|
 |
PREVENTION
References
- Preventive Medicine and Health Promotion at the CWRU School of Medicine: A review of the Published Curriculum of the First Three Years David Litaker, MD MSc
- Healthy People 2010 – Health Status http://www.healthypeople.gov/document/html/uih/uih_2.htm#status
- Canadian Guide to Clinical Preventive Health – Preventive Guidelines: Their Role in Clinical Prevention and Health Promotion http://www.hc-sc.gc.ca/hppb/healthcare/pubs/clinical_preventive/pdf/guide.pdf
- Canadian Guide to Clinical Preventive Health – Methodology http://www.hc-sc.gc.ca/hppb/healthcare/pubs/clinical_preventive/pdf/methe.pdf
- Guide to Clinical Preventive Services http://odphp.osophs.dhhs.gov/pubs/guidecps/PDF/Frontmtr.PDF
- Guide to Clinical Preventive Health – Improving the Delivery of Clinical Preventive Services
- Managing Hypertension: The Current Clinical Strategies. Norman M. Kaplan, M.D. Hypertension Disease Management Guide, 2000 Second Edition
- Unpublished data for 1999-2000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6, referenced by The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express)
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express)
- Reference Card from the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)
- Primary Prevention of Hypertension. Clinical and Public Health Advisory from the National High Blood Pressure Education Program. Whelton PK, Jiang H, Lawrence JA et al. JAMA 2002;288:1882-8
- Centers for Disease Control and Prevention (CDC) www.cdc.gov
- Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287: 1003-10.
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
- Douglas JG & Onwuzulike KC, 2002 ‘Pathophysiology of Essential (Primary) Hypertension’ in Hypertension Secrets pp26,7 eds. DE Hricik, JT Wright &, MC Smith, Hanley & Belfus Inc., Philadelphia
- Primary Prevention of Hypertension: Clinical and Public Health Advisory from the National High Blood Pressure Education Program
- Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. U.S. population data. Arch Intern Med. 1993;153(5):598 – 615
- Flack JM, Neaton J, Grimm R, et al. For the Multiple Risk Factor Intervention Trial Research Group. Blood pressure mortality among men with prior myocardial infarction. Circulation. 1995;92(9):2437-45.
- Whelton PK, Epidemiology of hypertension. Lancet. 1994; 344(8915):101-6.
- He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens. 1999;17(Suppl 2):S7-S13.
- Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young and middle-aged men and women. JAMA. 1999;282(21):2012-8
- Appel LJ, Statson WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993;349:454-457 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
- An Economic Evaluation of the JNC Hypertension Guidelines Using Data from a Randomized Controlled Trial J Am Board Fam Pract 12(2):105-114, 1999. © 1999 American Board of Family Practice
- Healthy People 2010. US Department of Health and Human Services, November 2000
- Data from 1988 -1994 – age adjusted to year 2000 standard
- Data from 1988 – age adjusted to year 2000 standard population
- Hypertension Online reference: Coresh J, et al. Arch Intern Med. 2001;161(9):1207-1216.
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express). Table 2 from unpublished data for 1999-2000 computed by M. Wolz, National Heart, Lung, and Blood Institute; JNC 6.
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) figure 1
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) figure 2
- JNC VI The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) Risk Stratification
- Lifestyle modification and Blood Pressure Control. Thomas G. Pickering, MD, Phil (Reprinted) JAMA , April 23/30, 2003 – Vol 289, No. 16: 2131-2
- Primary Prevention of Hypertension. Clinical and Public Health advisory from the National High Blood Pressure Education Program. Whelton PK, Jiang H, Lawrence JA et al.
- National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in diabetes. Hypertension 1994;23:145-58 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
- Korchen TA. Attenuation of hypertension by insulin-sensitizing agents. Hypertension 1996;28:219-223 in The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
- Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2002;358:1682-2 in The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express).
 |
|
 |
|
|